Thyroid eye disease (TED), also known as Graves’ eye disease or Graves’ ophthalmopathy, is an inflammatory condition in people with thyroid disease. Treatment may include medication, eye drops, and ...
Graves’ disease is an autoimmune disorder that primarily affects the thyroid gland. Approximately 27 percent of patients with Graves’ disease in North America will develop an eye disease that is known ...
Please provide your email address to receive an email when new articles are posted on . Surgery is considered in either of the two following situations: When there is active disease that is vision ...
At University of Utah Health, surgery for excessive tearing due to nasolacrimal duct obstruction involves a team approach with surgeons who have fellowship training in orbital and sinus specialties.
DEAR DR. ROACH: I had a total thyroidectomy in July 2022 for Graves’ disease. All the time leading up to this and almost all the time since, I’ve only had one short “active” period of thyroid eye ...
Nearly 2 years after their final infusion with the IGF-IR inhibitor teprotumumab (Tepezza), 82% of patients with thyroid eye disease did not need further treatment for their symptoms, revealed ...
If you have red, swollen, or bulging eyes, you might have thyroid eye disease, or TED. It’s important to talk with your doctor about these symptoms, especially if you have hyperthyroidism. Your doctor ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- ...
Thyroid eye disease is a chronic autoimmune disorder causing inflammation in the muscles and other tissues behind the eye. It can lead to other eye complications, including glaucoma. Thyroid eye ...
DEAR DR. ROACH: I had a total thyroidectomy in July 2022 for Graves’ disease. All the time leading up to this and almost all the time since, I’ve only had one short “active” period of thyroid eye ...
Radioactive iodine (RAI) treatment was associated with an increased risk of developing Graves' orbitopathy (GO) in patients with thyroid cancer. Patients who developed GO received significantly higher ...